Zomedica (AMEX:ZOM) reported quarterly losses of $(0.01) per share. The company reported $7.00 million in sales this quarter. This is a 10.24 percent increase over sales of $6.35 million the same period last year.
Zomedica Q3 EPS $(0.01), Sales $7.00M Up From $6.35M YoY
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.